News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,944 Results
Type
Article (39293)
Company Profile (284)
Press Release (649367)
Section
Business (204113)
Career Advice (1998)
Deals (35396)
Drug Delivery (89)
Drug Development (80919)
Employer Resources (168)
FDA (16126)
Job Trends (14813)
News (344981)
Policy (32478)
Tag
Academia (2541)
Alliances (49250)
Alzheimer's disease (1262)
Approvals (16087)
Artificial intelligence (145)
Bankruptcy (352)
Best Places to Work (11587)
Biotechnology (200)
Breast cancer (190)
Cancer (1376)
Cardiovascular disease (110)
Career advice (1666)
Cell therapy (283)
Clinical research (64747)
Collaboration (485)
Compensation (264)
COVID-19 (2546)
C-suite (109)
Data (1395)
Diabetes (177)
Diagnostics (6170)
Earnings (84990)
Employer resources (146)
Events (110180)
Executive appointments (397)
FDA (16813)
Funding (432)
Gene therapy (196)
GLP-1 (600)
Government (4334)
Healthcare (18709)
Infectious disease (2639)
Inflammatory bowel disease (111)
Interviews (310)
IPO (16357)
Job creations (3626)
Job search strategy (1419)
Layoffs (418)
Legal (7869)
Lung cancer (198)
Manufacturing (207)
Medical device (13241)
Medtech (13246)
Mergers & acquisitions (19210)
Metabolic disorders (461)
Neuroscience (1585)
NextGen Class of 2024 (6509)
Non-profit (4469)
Northern California (1703)
Obesity (262)
Opinion (184)
Parkinson's disease (98)
Patents (121)
People (56504)
Phase I (20138)
Phase II (28517)
Phase III (21255)
Pipeline (514)
Postmarket research (2561)
Preclinical (8568)
Radiopharmaceuticals (236)
Rare diseases (264)
Real estate (5892)
Regulatory (21704)
Research institute (2316)
Resumes & cover letters (350)
Southern California (1472)
Startups (3568)
United States (15266)
Vaccines (567)
Weight loss (182)
Date
Today (15)
Last 7 days (464)
Last 30 days (2375)
Last 365 days (35342)
2024 (35193)
2023 (40112)
2022 (51217)
2021 (55761)
2020 (54137)
2019 (46592)
2018 (35059)
2017 (32141)
2016 (31538)
2015 (37596)
2014 (31361)
2013 (26393)
2012 (28639)
2011 (29295)
2010 (27364)
Location
Africa (715)
Arizona (196)
Asia (37376)
Australia (6102)
California (3837)
Canada (1461)
China (309)
Colorado (173)
Connecticut (178)
Europe (79991)
Florida (538)
Georgia (136)
Illinois (387)
Indiana (225)
Maryland (636)
Massachusetts (2985)
Michigan (175)
Minnesota (292)
New Jersey (1108)
New York (1094)
North Carolina (744)
Northern California (1703)
Ohio (146)
Pennsylvania (930)
South America (1094)
Southern California (1472)
Texas (555)
Utah (108)
Washington State (401)
688,944 Results for "collagen matrix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix
August 1, 2024
·
2 min read
Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™
Axogen, Inc. announces the launch of its newest product, Avive+ Soft Tissue Matrix™. Avive+™ is intended for use as a soft tissue barrier and is a resorbable, multi-layer amniotic membrane allograft that provides temporary protection and tissue separation during the critical phase of peripheral nerve healing.
June 24, 2024
·
6 min read
Biotech Bay
Collagen Matrix Inc. Unveils New Brand and Name as Regenity Biosciences
Collagen Matrix, Inc. announced it has changed its name to Regenity Biosciences and unveiled a new visual identity and website.
March 28, 2023
·
3 min read
Lone Star Bio
FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
FibroBiologics, Inc. announced that Chief Scientific Officer, Hamid Khoja, Ph.D., will present on FibroBiologics’ wound care and psoriasis programs at the Extracellular Matrix (ECM) Pharmacology Congress in Copenhagen, Denmark, from June 17-19, 2024.
June 6, 2024
·
5 min read
Press Releases
RTI Surgical Completes Acquisition of Collagen Solutions
November 4, 2024
·
1 min read
Business
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides
Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), announced today that is has signed an exclusive license agreement with Tufts University (“Tufts”) to develop and commercialize patented technology covering 18 unique collagen peptides.
January 3, 2024
·
5 min read
Deals
Collagen Matrix Acquires Polyganics
Collagen Matrix, Inc., a global leader in regenerative medicine and a Linden Capital Partners portfolio company, announced the acquisition of Polyganics, B.V. Polyganics is a medical technology company that develops and manufactures bioresorbable medical devices.
October 5, 2022
·
5 min read
Pharm Country
Collagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market
Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen and other biomaterial-based medical devices, and Linden Capital Partners portfolio company (“Collagen Matrix” or “the Company”), announced today its 510(k) Clearance for a new Fibrillar Collagen Wound Dressing.
June 28, 2022
·
3 min read
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical implantations of its newest product, Avive+ Soft Tissue Matrix™.
April 29, 2024
·
5 min read
BioCapital
NextCure and Nordic Bioscience Publish Review Article on the Regulation of Tumor Immunity by Tumor Collagen
NextCure, Inc. (Nasdaq: NXTC) today announced the publication of a review article in the online journal Frontiers in Immunology, highlighting the need for targeting tumor collagen in the extracellular matrix (ECM) in the tumor microenvironment to enhance anti-tumor immunity.
September 7, 2023
·
4 min read
1 of 68,895
Next
